Results for tag: "Odomzo"

Odomzo is a brand of skin cancer drug used to treat advanced basal cell carcinoma (BCC). It is a type of immunotherapy, which works by stimulating the body's own immune system to fight cancer cells. Odomzo is a topical cream that is applied directly to the affected area. It is typically used in combination with other treatments, such as surgery or radiation therapy. Odomzo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced BCC in adults. The Odomzo market is composed of a variety of companies that produce and distribute the drug. These companies include Novartis, Sun Pharmaceuticals, and Mylan. Additionally, there are a number of generic versions of Odomzo available, which are produced by various generic drug manufacturers. The Odomzo market is highly competitive, with companies competing for market share and pricing. Companies must also ensure that their products meet the FDA's safety and efficacy standards. As a result, the Odomzo market is constantly evolving, with new products and formulations being developed to meet the needs of patients. Show Less Read more